2025 annual financial data
Grace Therapeutics 2025 Operating margin
Grace Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -23,752,730 USD and net income was -13,625,884 USD.
Operating cash flow was -14,904,000 USD.
Get free Grace Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -23,752,730 USD
- Net income
- -13,625,884 USD
- Operating cash flow
- -14,904,000 USD